4basebio PLC (LON:4BB) Insider Heikki Lanckriet Buys 46,500 Shares

4basebio PLC (LON:4BB) insider Heikki Lanckriet acquired 46,500 shares of the firm’s stock in a transaction that occurred on Friday, November 15th. The stock was purchased at an average cost of GBX 1,325 ($16.68) per share, with a total value of £616,125 ($775,682.99).

4basebio Stock Performance

4basebio stock opened at GBX 1,300 ($16.37) on Friday. The company has a 50 day moving average price of GBX 1,340.29 and a 200 day moving average price of GBX 1,414.87. 4basebio PLC has a 52 week low of GBX 520 ($6.55) and a 52 week high of GBX 1,820 ($22.91). The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The firm has a market capitalization of £166.53 million, a price-to-earnings ratio of -1,666.67 and a beta of 1.09.

About 4basebio

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines.